Berezina, T.A.; Berezin, O.O.; Novikov, E.V.; Lichtenauer, M.; Berezin, A.E.
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide. Biomolecules 2024, 14, 1615.
https://doi.org/10.3390/biom14121615
AMA Style
Berezina TA, Berezin OO, Novikov EV, Lichtenauer M, Berezin AE.
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide. Biomolecules. 2024; 14(12):1615.
https://doi.org/10.3390/biom14121615
Chicago/Turabian Style
Berezina, Tetiana A., Oleksandr O. Berezin, Evgen V. Novikov, Michael Lichtenauer, and Alexander E. Berezin.
2024. "Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide" Biomolecules 14, no. 12: 1615.
https://doi.org/10.3390/biom14121615
APA Style
Berezina, T. A., Berezin, O. O., Novikov, E. V., Lichtenauer, M., & Berezin, A. E.
(2024). Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide. Biomolecules, 14(12), 1615.
https://doi.org/10.3390/biom14121615
